Mirum Pharmaceuticals (MIRM) EBT Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 9,460.35% |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | -5,686.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,686.05% |
| Dec 31, 2025 | 79.63% |
| Sep 30, 2025 | 119.03% |
| Jun 30, 2025 | 77.26% |
| Mar 31, 2025 | 44.64% |
| Dec 31, 2024 | 31.24% |
| Sep 30, 2024 | 40.49% |
| Jun 30, 2024 | 67.44% |
| Mar 31, 2024 | 17.62% |
| Dec 31, 2023 | 2.36% |
| Sep 30, 2023 | 34.61% |
| Jun 30, 2023 | -120.12% |
| Mar 31, 2023 | 18.22% |
| Dec 31, 2022 | -163.05% |
| Sep 30, 2022 | 24.22% |
| Jun 30, 2022 | 23.68% |
| Mar 31, 2022 | 27.57% |
| Dec 31, 2021 | -13.01% |
| Sep 30, 2021 | -118.97% |
| Jun 30, 2021 | -88.76% |
| Mar 31, 2021 | -137.15% |
| Dec 31, 2020 | 466.53% |
| Sep 30, 2020 | -42.57% |
| Jun 30, 2020 | -71.48% |
| Mar 31, 2020 | -257.66% |